Nichols Jason J, Lievens Christopher W, Bloomenstein Marc R, Liu Haixia, Simmons Peter, Vehige Joseph
*OD, PhD, FAAO †OD, MS, FAAO ‡OD, FAAO §PhD ∥OD School of Optometry, University of Alabama at Birmingham, Birmingham, Alabama (JJN); Southern College of Optometry, Memphis, Tennessee (CWL); Schwartz Laser Eye Center, Scottsdale, Arizona (MRB); and Allergan Clinical Research, Irvine, California (HL, PS, JV).
Optom Vis Sci. 2016 Aug;93(8):979-86. doi: 10.1097/OPX.0000000000000878.
This study compared a new contact lens rewetting drop containing both carboxymethylcellulose and hyaluronic acid (CMC-HA) with a standard drop containing carboxymethylcellulose only (CMC). Symptoms of discomfort typical in lens wear and lid wiper epitheliopathy (LWE) were assessed over a 3-month period in a diverse sample of contact lens wearers.
Adapted daily-wear contact lens subjects using hydrogel, silicone hydrogel, or rigid gas permeable lenses were enrolled in this prospective, randomized, double-masked, parallel-group, 90-day study conducted at 15 clinical sites. Subjects were randomized 2:1 to CMC-HA (n = 244) or CMC alone (n = 121) with dosage at least four times per day, along with their habitual lens care system. At baseline and at days 7, 30, 60, and 90, subject-completed questionnaires, bulbar conjunctival staining, LWE, contact lens distance visual acuity (CLDVA), and standard safety measures were assessed.
At day 90, CMC-HA performed significantly better than CMC in ocular symptoms including dryness throughout the day (p = 0.006), and burning/stinging throughout the day (p = 0.02) and at the end of the day (p < 0.001). CMC-HA also performed numerically better for dryness at the end of day (p = 0.06). LWE staining was improved in the CMC-HA group at day 90 whereas it increased slightly in the CMC alone group, with a significant between-group difference (p = 0.009). CMC-HA also demonstrated greater reduction in conjunctival staining compared with CMC alone at day 90 (p = 0.08). No differences in CLDVA, contact lens wear time, acceptability, and product use were observed, and safety outcomes were similar between groups.
The addition of HA to a standard CMC rewetting drop improves clinical performance. In this comparison of rewetting drop efficacy in contact lens wearers, LWE was a useful clinical sign for differentiating clinical performance.
本研究将一种含有羧甲基纤维素和透明质酸(CMC-HA)的新型隐形眼镜润眼液与仅含羧甲基纤维素的标准润眼液(CMC)进行了比较。在为期3个月的时间里,对不同类型的隐形眼镜佩戴者样本评估了隐形眼镜佩戴时典型的不适症状和睑板腺上皮病变(LWE)。
本项前瞻性、随机、双盲、平行组、为期90天的研究在15个临床地点开展,纳入了使用水凝胶、硅水凝胶或硬性透气性隐形眼镜的日常佩戴隐形眼镜受试者。受试者按2:1随机分为CMC-HA组(n = 244)或单独使用CMC组(n = 121),每天至少用药4次,并使用其习惯的镜片护理系统。在基线以及第7、30、60和90天,评估受试者填写的问卷、球结膜染色、LWE、隐形眼镜远视力(CLDVA)以及标准安全指标。
在第90天,CMC-HA在眼部症状方面表现显著优于CMC,包括全天的眼干(p = 0.006)、全天的灼痛/刺痛(p = 0.02)以及一天结束时的灼痛/刺痛(p < 0.001)。CMC-HA在一天结束时的眼干情况在数值上也表现更好(p = 0.06)。在第90天,CMC-HA组的LWE染色有所改善,而单独使用CMC组略有增加,两组间差异显著(p = 0.009)。在第90天,与单独使用CMC相比,CMC-HA在结膜染色方面的改善也更明显(p = 0.08)。未观察到CLDVA、隐形眼镜佩戴时间、可接受性和产品使用方面的差异,两组的安全性结果相似。
在标准的CMC润眼液中添加HA可改善临床效果。在本次隐形眼镜佩戴者润眼液疗效比较中,LWE是区分临床效果的有用临床指标。